Performance of the four-plex tandem mass spectrometry lysosomal storage disease newborn screening test: The necessity of adding a 2nd tier test for Pompe disease

Chiang S.-C.Chen P.-W.WUH-LIANG HWULee A.-J.Chen L.-C.NI-CHUNG LEEChiou L.-Y.YIN-HSIU CHIEN2020-12-092020-12-0920182409-515Xhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85059702799&doi=10.3390%2fijns4040041&partnerID=40&md5=f4c8cabd7a1f8994f1c65a1b2a13da8fhttps://scholars.lib.ntu.edu.tw/handle/123456789/525089[SDGs]SDG3Performance of the four-plex tandem mass spectrometry lysosomal storage disease newborn screening test: The necessity of adding a 2nd tier test for Pompe diseasejournal article10.3390/ijns40400412-s2.0-85059702799